Skip to main content

Peer Review reports

From: Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

Original Submission
22 Dec 2006 Submitted Original manuscript
10 Feb 2007 Reviewed Reviewer Report - Giovanni Cammarota
19 Feb 2007 Reviewed Reviewer Report - TJ Borody
7 Mar 2007 Reviewed Reviewer Report - Colm O'Morain
28 Mar 2007 Author responded Author comments - Jose María Navarro-Jarabo
Resubmission - Version 2
28 Mar 2007 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Apr 2007 Reviewed Reviewer Report - TJ Borody
2 May 2007 Author responded Author comments - Jose María Navarro-Jarabo
Resubmission - Version 4
2 May 2007 Submitted Manuscript version 4
21 May 2007 Reviewed Reviewer Report - Colm O'Morain
26 Jun 2007 Author responded Author comments - Jose María Navarro-Jarabo
Resubmission - Version 5
26 Jun 2007 Submitted Manuscript version 5
5 Jul 2007 Author responded Author comments - Jose María Navarro-Jarabo
Resubmission - Version 6
5 Jul 2007 Submitted Manuscript version 6
20 Jul 2007 Author responded Author comments - Jose María Navarro-Jarabo
Resubmission - Version 7
20 Jul 2007 Submitted Manuscript version 7
Publishing
25 Jul 2007 Editorially accepted
25 Jul 2007 Article published 10.1186/1471-230X-7-31

You can find further information about peer review here.

Back to article page